Does LEUPROLIDE Cause Ecchymosis? 7 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Ecchymosis have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.0% of all adverse event reports for LEUPROLIDE.
7
Reports of Ecchymosis with LEUPROLIDE
0.0%
of all LEUPROLIDE reports
2
Deaths
2
Hospitalizations
How Dangerous Is Ecchymosis From LEUPROLIDE?
Of the 7 reports, 2 (28.6%) resulted in death, 2 (28.6%) required hospitalization.
Is Ecchymosis Listed in the Official Label?
Yes, Ecchymosis is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Ecchymosis?
RIVAROXABAN (398)
ASPIRIN (344)
WARFARIN (248)
CLOPIDOGREL BISULFATE (205)
IBRUTINIB (189)
APIXABAN (154)
METHOTREXATE (131)
PREDNISONE (118)
TOCILIZUMAB (92)
DABIGATRAN ETEXILATE (79)
Which LEUPROLIDE Alternatives Have Lower Ecchymosis Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM